Risk factors for prevalent diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes
- 112 Downloads
Age at diagnosis of type 1 diabetes (DM1) has been implied as an important factor associated with the development of the microvascular complications. Our aim was to identify factors associated with prevalent diabetic retinopathy (DR) and proliferative diabetic retinopathy (PDR) in DM1 people with early and late-onset.
We reviewed medical records from all DM1 people from the reference area of a tertiary center (about 340,000 persons). Univariate and multivariate logistic regression were used to assess the relationship between potential risk factors (sociodemographic, diabetes-related, co-morbidities, and laboratory parameters) and prevalent DR/PDR. We performed an analysis comparing patients diagnosed before (early-onset) and after (late-onset) 18 years of age.
We included 140 patients in early-onset DM1 group and 169 in late-onset DM1 group. Longer duration of diabetes and HbA1c remained associated with prevalent DR in both groups after adjusting for potential risk factors. Nephropathy was associated with prevalent DR in the late-onset group but not in the early-onset group. Peripheral neuropathy remained associated with prevalent PDR when modeled together in the multivariate model. High BMI demonstrated a significative association with PDR in early but not in the late-onset DM1 group.
Although previous reports suggest that age at DM1 diagnosis may have a role in DR prevalence, the risk factors for DR in early and late-onset DM1 were similar for both groups. Duration of disease and lifelong metabolic control were the major predictors for DR in both groups. Nephropathy was associated with DR in patients with late-onset disease. Neuropathy was associated with PDR occurrence in both groups. BMI was associated with PDR early-onset DM1 group.
Keywordsdiabetic retinopathy type 1 diabetes late-onset risk factors microvascular disease
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.International Diabetes Federation. Diabetes Atlas, 8th edn. www.diabetesatlas.org. 2018. Accessed 8 Aug 2018.
- 5.N.J. Thomas, S.E. Jones, M.N. Weedon, B.M. Shields, R.A. Oram, A.T. Hattersley, Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 6(2), 122–129 (2018). https://doi.org/10.1016/S2213-8587(17)30362-5 CrossRefPubMedPubMedCentralGoogle Scholar
- 6.T. Bulum, M. Tomic, L. Duvnjak, Total serum cholesterol increases risk for development and progression of nonproliferative retinopathy in patients with type 1 diabetes without therapeutic intervention: Prospective, Observational Study. Arch. Med Res. 48(5), 467–471 (2017). https://doi.org/10.1016/j.arcmed.2017.10.003 CrossRefPubMedGoogle Scholar
- 13.S.Y. Wang, C.A. Andrews, W.H. Herman, T.W. Gardner, J.D. Stein, Incidence and risk factors for developing diabetic retinopathy among youths with type 1 or type 2 diabetes throughout the United States. Ophthalmology 124(4), 424–430 (2017). https://doi.org/10.1016/j.ophtha.2016.10.031 CrossRefPubMedGoogle Scholar
- 14.A. Penman, H. Hancock, E. Papavasileiou, et al., Risk factors for proliferative diabetic retinopathy in african americans with type 2 diabetes risk factors for proliferative diabetic retinopathy in African Americans with. 6586 (2016). https://doi.org/10.3109/09286586.2015.1119287 CrossRefGoogle Scholar
- 15.R.V. Rivera-Virtudazo, A.K.G. Tapia, J.F.B. Valenzuela, L.D. Cruz, H.D. Mendoza, E.V. Castriciones, Lacunarity Analysis of TEM Images of Heat-Treated Hybrid Organosilica Materials. In: Innovations in Chemical Biology. Dordrecht: Springer Netherlands, Dordrechtp. 397–403. https://doi.org/10.1007/978-1-4020-6955-0_47
- 16.M. Nordwall, M. Fredriksson, J. Ludvigsson, H.J. Arnqvist, Impact of age of onset, puberty, and glycemic control followed from diagnosis on incidence of retinopathy in type 1 diabetes: The VISS study. Diabetes Care. 42(4), 609–616 (2019). https://doi.org/10.2337/dc18-1950 CrossRefPubMedGoogle Scholar
- 18.C.E. Kullberg, M. Abrahamsson, H.J. Arnqvist, K. Finnström, J. Ludvigsson, VISS Study Group. Prevalence of retinopathy differs with age at onset of diabetes in a population of patients with Type 1 diabetes. Diabet Med. 19(11):924–931. (2002). http://www.ncbi.nlm.nih.gov/pubmed/12421429. Accessed 29 Aug 2018CrossRefGoogle Scholar
- 19.Census 2011. INE, Instituto Nacional de Estatística (Statistics Portugal). (2011) https://www.ine.pt. Accessed 20 Aug 2008.
- 22.Diabetes Control and Complications Trial Research Group, D.M. Nathan, S. Genuth, et al., The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329(14), 977–986 (1993). https://doi.org/10.1056/NEJM199309303291401 CrossRefGoogle Scholar
- 23.UKPDS., Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (Lond., Engl.). 352(9131), 837–853 (1998). http://www.ncbi.nlm.nih.gov/pubmed/9742976 Accessed 7 Oct 2018.
- 26.L. Forga, M.J. Goñi, B. Ibáñez, K. Cambra, M. García-Mouriz, A. Iriarte, Influence of age at diagnosis and time-dependent risk factors on the development of diabetic retinopathy in patients with type 1 diabetes. J. Diabetes Res. 2016, 9898309 (2016). https://doi.org/10.1155/2016/9898309 CrossRefPubMedPubMedCentralGoogle Scholar